India has emerged as a leading destination for world-class cancer care at a fraction of international costs. What makes it "world-class" is not just price—it's the combination of evidence-based protocols, specialist expertise, and transparent pricing that together deliver unbeatable value for international patients.
The Blueprint: Indian Tumor Board Consensus
Your treatment pathway is built on global oncology guidelines—National Comprehensive Cancer Network (NCCN), National Cancer Grid (NCG) India—and validated by a multidisciplinary Tumor Board. This means your plan is not one doctor's opinion but a consensus from surgical, medical, and radiation oncologists, radiologists, and pathologists. The result is a structured, evidence-linked clinical blueprint tailored to your case.
The Expertise: Tata Memorial & AIIMS-Trained Specialists
India is home to Tata Memorial Hospital, AIIMS, and other premier cancer institutions. Oncologists trained at these centers lead care at JCI-accredited hospitals across the country. You receive the same guideline-aligned, high-volume expertise that defines global best practice—with the added advantage of direct pricing and shorter wait times.
The Price: India Advantage + Direct Pricing
Advanced cancer care in India typically costs 70–80% less than in the USA, UK, or UAE. Transparent rate-card pricing and fair commission structures mean you see the breakdown before you commit. No hidden markups—just clear, itemized estimates so you can plan with confidence.
Accessibility Advantage
India offers one of the fastest medical visa approval processes globally. Combined with streamlined intake and Tumor Board review, you can move from first contact to a clear treatment plan—and then to India—without long delays. That accessibility is part of the value: world-class care when you need it.
Ready to see what this means for your case?
Explore Why India